Central mechanisms of the hypertensive action of intraventricular bradykinin in the unanaesthetized rat.
D000470:Alkaloids / Q000494:pharmacology; D000577:Amides / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D001593:Benzyl Compounds / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects*; D001920:Bradykinin / Q000008:administration & dosage / Q000494:pharmacology*; D002396:Catechols / Q000494:pharmacology; D002404:Catheterization; D002552:Cerebral Ventricles / Q000187:drug effects; D004155:Diphenhydramine / Q000008:administration & dosage / Q000494:pharmacology; D004600:Eledoisin / Q000494:pharmacology; D005029:Ethylenediamines / Q000494:pharmacology; D005231:Fatty Acids, Unsaturated / Q000494:pharmacology; D006584:Hexamethonium Compounds / Q000494:pharmacology; D007267:Injections; D007269:Injections, Intra-Arterial; D007609:Kallidin / Q000494:pharmacology; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008297:Male; D008784:Methysergide / Q000494:pharmacology; D009020:Morphine / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D051381:Rats; D013238:Stereotaxic Techniques; D013997:Time Factors
D000470:Alkaloids; D000577:Amides; D001593:Benzyl Compounds; D002396:Catechols; D005029:Ethylenediamines; D005231:Fatty Acids, Unsaturated; D006584:Hexamethonium Compounds; D011725:Pyridines; D007609:Kallidin; D004600:Eledoisin; D009020:Morphine; D001285:Atropine; D004155:Diphenhydramine; D008238:Lysergic Acid Diethylamide; D011433:Propranolol; D001920:Bradykinin; D009638:Norepinephrine; D008784:Methysergide; D010646:Phentolamine